Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use - PubMed (original) (raw)
Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use
Eng-Joo Phua et al. Diabetes Care. 2013 Dec.
No abstract available
Similar articles
- Human insulin analog--induced lipoatrophy.
Lopez X, Castells M, Ricker A, Velazquez EF, Mun E, Goldfine AB. Lopez X, et al. Diabetes Care. 2008 Mar;31(3):442-4. doi: 10.2337/dc07-1739. Epub 2007 Dec 27. Diabetes Care. 2008. PMID: 18162498 - [Lipoatrophy after insulin injections can be treated with lipofilling].
Lund PS, Sjøstrand H, Matzen SH. Lund PS, et al. Ugeskr Laeger. 2016 Dec 5;178(49):V07160480. Ugeskr Laeger. 2016. PMID: 27959262 Danish. - Lipoatrophy is a thing of the past, or is it?
Hussein SF, Siddique H, Coates P, Green J. Hussein SF, et al. Diabet Med. 2007 Dec;24(12):1470-2. doi: 10.1111/j.1464-5491.2007.02300.x. Epub 2007 Nov 1. Diabet Med. 2007. PMID: 17976201 - Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.
Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E. Pozzilli P, et al. Diabetes Metab Res Rev. 2016 Jan;32(1):21-39. doi: 10.1002/dmrr.2653. Epub 2015 Jun 22. Diabetes Metab Res Rev. 2016. PMID: 25865292 Free PMC article. Review. - Pharmacologic treatment options for type 1 diabetes: what's new?
Nally LM, Sherr JL, Van Name MA, Patel AD, Tamborlane WV. Nally LM, et al. Expert Rev Clin Pharmacol. 2019 May;12(5):471-479. doi: 10.1080/17512433.2019.1597705. Expert Rev Clin Pharmacol. 2019. PMID: 30892094 Free PMC article. Review.
Cited by
- Medication Repurposing in Pediatric Patients: Teaching Old Drugs New Tricks.
Rumore MM. Rumore MM. J Pediatr Pharmacol Ther. 2016 Jan-Feb;21(1):36-53. doi: 10.5863/1551-6776-21.1.36. J Pediatr Pharmacol Ther. 2016. PMID: 26997928 Free PMC article. - Laser treatment for lipoatrophy in children with diabetes type 1.
Xatzipsalti M, Alvertis H, Vazeou A. Xatzipsalti M, et al. Diabetol Int. 2021 Oct 3;13(2):452-455. doi: 10.1007/s13340-021-00547-w. eCollection 2022 Apr. Diabetol Int. 2021. PMID: 35463860 Free PMC article. - Prevalence, Risk Factors, and Clinical Characteristics of Lipodystrophy in Insulin-Treated Patients with Diabetes: An Old Problem in a New Era of Modern Insulin.
Thewjitcharoen Y, Prasartkaew H, Tongsumrit P, Wongjom S, Boonchoo C, Butadej S, Nakasatien S, Karndumri K, Veerasomboonsin V, Krittiyawong S, Himathongkam T. Thewjitcharoen Y, et al. Diabetes Metab Syndr Obes. 2020 Nov 26;13:4609-4620. doi: 10.2147/DMSO.S282926. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 33273836 Free PMC article. - Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?
Gentile S, Strollo F, Ceriello A; AMD-OSDI Injection Technique Study Group. Gentile S, et al. Diabetes Ther. 2016 Sep;7(3):401-9. doi: 10.1007/s13300-016-0187-6. Epub 2016 Jul 25. Diabetes Ther. 2016. PMID: 27456528 Free PMC article. Review. - ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes.
Mahmud FH, Elbarbary NS, Fröhlich-Reiterer E, Holl RW, Kordonouri O, Knip M, Simmons K, Craig ME. Mahmud FH, et al. Pediatr Diabetes. 2018 Oct;19 Suppl 27(Suppl 27):275-286. doi: 10.1111/pedi.12740. Pediatr Diabetes. 2018. PMID: 30066458 Free PMC article. No abstract available.
References
- Holstein A, Stege H, Kovacs P. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature. Expert Opin Drug Saf 2010;9:225–231 - PubMed
- Babiker A, Datta V. Lipoatrophy with insulin analogues in type I diabetes. Arch Dis Child 2011;96:101–102 - PubMed
- Lopez X, Castells M, Ricker A, Velazquez EF, Mun E, Goldfine AB. Human insulin analog–induced lipoatrophy. Diabetes Care 2008;31:442–444 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical